DNAdamAge Error or Program? Resolving the Mechanisms of Ageing via High-Resolution Cross-Species Mapping of Major DNA-Damage Types
- Coordinator
- Universite De Lausanne, Switzerland
- Runs
- 1 April 2027 to 31 March 2032
- Status
- Running
- EU funding
- €2.5m
- Total cost
- €2.5m
- Partners
- 1 organisations in 1 countries
- Type
- European Research Council grant
- Grant agreement
- 101301744
What the project is doing
In the project's own words, from its summary on CORDIS.
Societies are ageing, creating an urgent need to uncover the molecular drivers of decline and to enable healthy-ageing therapies. DNA damage and repair are causal in age-related dysfunction, yet accurate direct in vivo measurements of DNA damage are scarce, and it remains unclear which lesion types matter, where they accumulate, and how they disrupt gene control. We will generate genome-wide maps of major DNA-damage types at single-nucleotide resolution in human blood and multiple mouse tissues using our novel artefact-controlled sequencing technologies.
This will allow defining how DNA damage reshapes transcriptional regulation and contributes to epigenetic ageing signatures. Aim 1: We will profile guanine oxidation and abasic sites in 800 human buffy-coat (leukocyte) samples (18–80 years) and link lesion landscapes to multi-omic, clinical and exposure data. We will build and validate DNA-damage clocks of chronological and biological age and test associations with morbidity and lifestyle.
Aim 2: We will map strand breaks, guanine oxidation and abasic sites across multiple mouse tissues in both sexes over the lifespan, with matched RNA-seq and methylomes, to distinguish tissue-specific from shared ageing DNA-damage trajectories and to assess conservation of human signals. Aim 3: We will interrogate slowed-ageing mouse models (rapamycin+acarbose, caloric restriction) and accelerated-ageing mice (repair deficiency) to test mechanistic links between locus-specific damage, gene expression and methylation patterns and to assess if the lifespan-extending interventions restore youthful damage landscapes.
Outcomes: We will deliver the first cross-species, single-nucleotide maps of multiple DNA lesions in physiological tissues in aging, identify genomic vulnerability hotspots and their effects on physiology, test competing program- and error-based frameworks of ageing, and produce mechanistically grounded biomarkers and targets to evaluate health-span-extending therapies.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Universite De Lausanne | Lausanne | Switzerland | Coordinator |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI